Optimizing the acceptability, effectiveness and costs of immunization programs: the Quebec experience-Reference-Cited by-同舟云学术

Optimizing the acceptability, effectiveness and costs of immunization programs: the Quebec experience

Published:2011-01 Issue:1 Volume:10 Page:55-62
ISSN:1476-0584
Container-title:Expert Review of Vaccines
language:en
Short-container-title:Expert Review of Vaccines

Author:

Wals Philippe De

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,Molecular Medicine,Immunology

Link

http://www.tandfonline.com/doi/pdf/10.1586/erv.10.151

Reference43 articles.

1. Linteau PA, Durocher R, Robert JC, Ricard F.Histoire du Québec Contemporain. Le Québec Depuis 1930. Tome 2. Nouvelle Edition Révisée.Les Éditions du Boréal, Montréal, QC, Canada (1989).

2. Public Health Agency of Canada.Canadian Immunization Guide (7th Edition). Public Health Agency of Canada, Ottawa, ON, Canada (2006).

3. Canada's National Advisory Committee on Immunization (NACI): Evidence-based decision-making on vaccines and immunization

4. An analytical framework for immunization programs in Canada

5. Effectiveness of a Mass Immunization Campaign Using Serogroup C Meningococcal Conjugate Vaccine

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Can BCG be useful to mitigate the COVID-19 pandemic? A Canadian perspective;Canadian Journal of Public Health;2020-11-19

2. Epidemiology and Control of Meningococcal Disease in Canada: A Long, Complex, and Unfinished Story;Canadian Journal of Infectious Diseases and Medical Microbiology;2019-11-25

3. Kingdon’s Multiple Streams Framework and the Analysis of Decision-Making Processes Regarding Publicly-Funded Immunization Programs.;Expert Review of Vaccines;2019-06-03

4. Early use of the HPV 2-dose vaccination schedule: Leveraging evidence to support policy for accelerated impact;Vaccine;2018-08

5. Policy making for vaccine use as a driver of vaccine innovation and development in the developed world;Vaccine;2017-03